Kelly K. Gillespie is a professor and the incoming director of the Center for Health Law Studies at Saint Louis University. Dr. Gillespie is an expert in health law and bioethics. Her scholarship, informed by her nursing practice, centers on the impact of legal and ethical norms on clinical care and public health policy. Her recent work has focused on the subjugating effects of harm-inducing laws on people with substance use disorders, chronic pain, and other intersecting stigmatized and minoritized identities. Dr. Gillespie was recently appointed to the National Institute on Drug Abuse’s Partner Consultation Board for the Long-Term Opioid Therapy Research Network. She also co-authored two amici briefs before the Supreme Court on behalf of U.S. professors of health law and policy in Ruan v. U.S. and has served by invitation for both the ABA and AHLA on working groups on the opioid related crises. She co-edited “Prescription Drug Diversion and Pain: History, Policy, and Treatment” (Oxford University Press), and her writing has appeared in the Cato Supreme Court Review, Arizona State Law Review, JLME, the American Journal of Bioethics, the Journal of Addiction Medicine, among others.
